Document is current
Any future updates will be listed below
-
Authors
Hasan, Shemonti
Guo, Yong
Sandroni, Paola
Dubey, Divyanshu
McKeon, Andrew
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (RO1NS126227)
- License Information
-
More Information
Article History
Received: 17 October 2024
Accepted: 5 January 2025
First Online: 15 January 2025
Declarations
:
: SH, YG, and PS have no competing interests to disclose. AM has patent applications pending for septin-5 and -7-IgGs as biomarkers of autoimmune neurologic disease. DD has received research support from the Center of Multiple Sclerosis and Autoimmune Neurology, Center of Individualized Medicine, and Grifols Pharmaceuticals, and consulted for UCB and Astellas pharmaceuticals; all compensation for consulting activities is paid directly to Mayo Clinic.
